Sermorelin Therapy Editorial is an independent editorial reference dedicated to one narrow topic: how sermorelin therapy and related growth hormone releasing peptides are studied, prescribed, compounded, and discussed in the United States. We exist so that an adult reader can arrive on the site, spend half an hour, and leave with a clearer mental map of the field before talking to a licensed clinician.
What we are not. [We do not diagnose, treat, prescribe, dispense, ship, or sell anything. When an article describes a clinical situation, that description is editorial — drawn from published literature and from the routine practice patterns reported by clinicians — not a personal recommendation from us to you. For an explicit statement of what the site is not, see our Disclaimer.
Editorial mission. The growth hormone releasing peptide field is unusually fragmented. The primary literature lives in endocrinology journals; the regulatory rules live in FDA guidance documents, state pharmacy board rulings, and USP compounding chapters; the clinical practice lives in a small number of specialised clinics; and the public discussion lives in podcasts, anecdotal forums, and marketing copy of uneven quality. Our mission is to write the calm, neutral, source-anchored reference that we wished existed when we started reading on the topic. We try to be useful to a reader who already has questions for their doctor, not to a reader who is looking for a sales pitch.
How we choose topics. We start from the questions readers send us through the contact form and from the gaps we notice in our own reading of the field. We prioritise topics where the literature is solid enough to summarise but the public-facing material is poor, and we deprioritise topics where reliable summaries already exist elsewhere.
Sources and review. Articles are drafted from peer-reviewed publications, regulatory documents, professional society position papers, and reputable clinical journalism. We name our sources in line, link to them where stable URLs exist, and prefer primary sources over secondary commentary. Every article passes through at least two editorial reads before publication: one for factual accuracy against the cited sources, and one for clarity, tone, and consistency with the rest of the site. We correct errors openly; if you spot one, please tell us using the form on the page.
Independence. Sermorelin Therapy Editorial is editorially independent. We do not coordinate our coverage with clinics, pharmacies, or peptide vendors, and we do not give those parties advance notice of articles that involve them. If a topic involves a financial relationship of any kind, that relationship is disclosed in the article itself.
Updates. Long-form articles carry the date of last review at the top. When a regulatory change, a major trial, or a significant safety signal lands in the field, we re-read the affected pages and revise them; the revision date is updated accordingly.
Get in touch. Questions, corrections, and suggestions are welcome at Sermorelin Therapy Editorial
1209 Orange Street
Wilmington, DE 19801
United States or by phone at +1 (302) 555-0148. The fastest way to reach the editors is the form on the page.
The brief in the United States, USA
Sermorelin is a synthetic 29 amino acid peptide that copies the first portion of natural growth hormone releasing hormone. Administered as a small subcutaneous injection at night, it signals the pituitary gland to release the body's own growth hormone in a pulsatile, physiologic rhythm. That mechanism is the entire reason adults consider it.
Unlike injected human growth hormone, sermorelin keeps the body's natural feedback loop intact. The pituitary continues to regulate output. Levels rise within a window that resembles a younger adult's overnight pulse, then fall. Recovery, sleep depth, body composition and skin quality are the outcomes most commonly described.
For adults across the United States, USA, sermorelin is dispensed exclusively as a compounded preparation by licensed 503A and 503B pharmacies, after a US-licensed clinician writes a prescription. The branded sermorelin product approved decades ago was discontinued. The current treatment requires a real consultation, a real lab panel, and a real prescription. None of that is bypassed by telehealth.
Mechanism, in plain words
Natural growth hormone is released by the pituitary in short overnight pulses. With age, the size and frequency of these pulses fall. Output at 55 looks nothing like output at 25. Most of the visible age signals associated with growth hormone decline, from softer sleep to slower healing to gradual fat redistribution, follow from that drop.
Sermorelin asks the pituitary to do its old job. It binds the same receptor that natural GHRH binds, and triggers the same release. Because the body's negative feedback loop remains in place, sermorelin cannot push growth hormone past the body's own safety ceiling. This is the structural reason it is generally considered safer than injected synthetic HGH.
What it is not
Sermorelin is not anabolic in the way testosterone is anabolic. It is not a fat loss drug. It is not a performance enhancer, and is not legally prescribed for that purpose. It is not a substitute for sleep, training, or protein. It is also not a quick result. The body needs months to fully translate restored GH pulses into measurable change.
Where the evidence sits
The clinical record on sermorelin runs back to the late 1970s, when GHRH-29 was first synthesized. Trials in growth hormone deficient children supported FDA approval of the branded form. In adults, the strongest peer-reviewed evidence covers a narrower set of outcomes, primarily IGF-1 response, body composition changes over 12 to 24 weeks, and self-reported sleep and recovery quality.
Three considerations belong in any honest reading. First, modern compounded sermorelin is not a separately approved drug. Second, most public testimonials on the wellness side conflate sermorelin with the broader peptide stack patients also use. Third, the published evidence does not support sermorelin as a cosmetic anti-aging treatment, and credible providers do not market it as one.
Sermorelin is a tool for restoring physiologic pulses, not a tool for pushing growth hormone past where the body would naturally take it. The clinical case is honest only when framed that way.
The standard protocol
A first cycle generally runs 12 weeks, with a follow-up IGF-1 lab drawn at the end. Doses are dialed by the prescribing clinician based on baseline labs, body weight, and tolerance. The most common pattern in current US telehealth practice looks like this.
- Intake and baseline labHealth questionnaire on energy, sleep, recovery, training, sexual function. Baseline IGF-1, fasting glucose, complete metabolic panel, lipid panel.
- Clinician reviewA licensed clinician confirms medical appropriateness. If not appropriate, the consultation is refunded. If appropriate, dose is calculated.
- DispensingCompounded sermorelin acetate is mailed from a 503A or 503B partner pharmacy with insulin syringes, alcohol pads, sharps container.
- Self-administrationSingle subcutaneous injection at night, on an empty stomach. Standard schedule, five nights on and two nights off. Twelve weeks.
- ReassessmentFollow-up IGF-1 at week 12. Dose held, raised, lowered, or paused based on labs and self-reported response.
How to obtain a real prescription
Legitimate sermorelin in the United States moves through a narrow channel. A licensed clinician in your state writes a prescription to a registered compounding pharmacy. Anything outside that channel, especially products purchased from research peptide vendors without prescription, sits outside the medical and legal model.
The telehealth provider referenced on this site operates in all 50 states, runs the intake through a licensed clinician, uses 503A and 503B partner pharmacies, and issues a full refund if the clinical decision is that sermorelin is not appropriate. That last point matters. A provider unwilling to refuse a prescription is not practicing medicine.
Questions readers ask
Is sermorelin FDA approved?
The original branded sermorelin product was approved and is no longer sold. The form prescribed today is a compounded preparation made by licensed pharmacies under sections 503A and 503B. Compounded preparations are not separately FDA approved, and that is disclosed at consultation.
How is this different from HGH?
HGH is the growth hormone molecule itself, supplied externally. Sermorelin is a releasing peptide that prompts the body's own pituitary to make growth hormone. Sermorelin preserves the body's natural ceiling. HGH does not.
What results do adults actually report?
The most consistent reports are improved sleep depth in the first four weeks, recovery and skin quality in the second month, and body composition with modest fat loss and small lean mass gains in months three and four. Libido and joint comfort are commonly mentioned later in the cycle.
Is it safe?
Reported side effects are generally mild, the most common being mild injection site redness, transient flushing, and occasional headache. Because sermorelin works through the body's own pituitary, the negative feedback loop limits supraphysiological exposure. Clinical contraindications are screened during intake.
What does a course cost?
A standard 12 week program through US telehealth typically runs between 180 and 240 dollars per month, including the clinician visit, labs, the medication, and supplies. HSA and FSA cards are accepted at most providers. Insurance generally does not cover compounded peptides.
Is the prescription legitimate?
Yes if the provider is a licensed telehealth network using a clinician licensed in your state and a registered compounding pharmacy. A copy of the prescription accompanies the shipment. Off-channel research peptide vendors are not part of this model.
Is sermorelin legal where I live?
Sermorelin is legal across the United States when prescribed by a US-licensed clinician. The compounded preparation is dispensed under federal sections 503A and 503B, and the prescription is written by a clinician licensed in your jurisdiction.
Speak with a licensed clinician in the United States, USA
Online intake, blood panel, a real clinical decision. If sermorelin is not for you, you are not prescribed it.
Start your consultation